Stay updated on Comparing Ocrelizumab and Ofatumumab in MS Clinical Trial

Sign up to get notified when there's something new on the Comparing Ocrelizumab and Ofatumumab in MS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Comparing Ocrelizumab and Ofatumumab in MS Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The clinical trial record for the TIMIOS study is displayed, including its study overview, participant criteria, locations, design, and outcome measures.
    Difference
    38%
    Check dated 2026-11-11T01:35:57.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The footer revision label was updated from v3.7.2 to v3.8.0 while the page continued to display a 403 error.
    Difference
    0.2%
    Check dated 2026-11-03T23:46:28.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    A site-wide NIH notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears, and the site revision changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T23:52:15.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    The footer’s site revision indicator changed from v3.7.0 to v3.7.1, while the page still displays a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-10-07T01:03:13.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The study page now shows a 403 Forbidden error, replacing the expected study details with an error page. This indicates the page is currently inaccessible due to permissions or server configuration.
    Difference
    16%
    Check dated 2026-09-23T00:48:56.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.6 to v3.7.0, indicating the current revision of the page. This reflects a metadata update rather than a substantive change to study information.
    Difference
    0.1%
    Check dated 2026-09-15T23:57:52.000Z thumbnail image

Stay in the know with updates to Comparing Ocrelizumab and Ofatumumab in MS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Comparing Ocrelizumab and Ofatumumab in MS Clinical Trial page.